
- HIV Reagent Kits
- Stem Cell Enumeration
- BD Multicheck™ Control
- Other Species Cell Separation Reagents
- BD Facsunt™ 控制套件
- Single-Color Antibodies
- BD™ Stem Cell Control Kit
- Sample Multiplexing Reagents
- 纯化抗体
- Isotype Controls
- BD Reti-Count™ Kit
- Compensation Particles
- 人体细胞分离试剂
- BD Leucocount™ Control Kit Bi-Level Control
- 研究试剂
- 细胞凋亡
- BD钙测定试剂盒
- BD Leuocount™ Reagent System
- Caspase Substrates and Inhibitors
- 抗体寡结合物
- 多色鸡尾酒

Description
BD™ Multi-Check Control is intended as a complete process control for immunophenotyping by flow cytometry. It is a control for antibody staining, red blood cell (RBC) lysis, instrument setup and performance, and data analysis on BD FACSLyric™, BD FACSCanto™ II, BD FACSCanto™, and BD FACSCalibur™ flow cytometers.
Resources & Tools | ||||||
---|---|---|---|---|---|---|
SpectrumViewer | Download MSDS |
Preparation and Storage
•Store vials upright, tightly capped, at 2°C–8°C when not in use.
• Unopened vials are stable until the expiration date indicated on each vial and Assay Values sheet.
• Opened vials are stable for 9 thermal cycles (uses) when handled properly. A thermal cycle constitutes performing all steps under Instructions for Use.
• Avoid unnecessary cycles of warming and cooling. Protect from freezing, from temperatures above 30°C, and from prolonged time (>30 minutes) at room temperature (20°C–25°C). Follow exactly the steps underInstructions for Use.
- Enumeration of Immunologically Defined Cell Populations by Flow Cytometry; Approved Guideline—Second Edition. Wayne, PA: Clinical and Laboratory Standards Institute; 2007. CLSI document H42-A2.
- Clinical Flow Cytometric Analysis of NeoplasticHematolymphoid Cells; Approved Guideline—Second Edition. Wayne, PA: Clinical and LaboratoryStandards Institute; 2007. CLSI document H43-A2.
- Centers for Disease Control. 1997 Revisedguidelines for performing CD4+ T-celldeterminations in persons infected with humanimmunodeficiency virus (HIV). MMWR. 1997;46:1-29.
- Stelzer GT, Marti G, Hurley A, McCoy P Jr,Lovett EJ, Schwartz A. US-Canadian Consensusrecommendations on the immunophenotypicanalysis of hematologic neoplasia by flowcytometry: standardization and validation oflaboratory procedures. Cytometry. 1997;30:214-230.